Head to Head Survey: Aspyra (OTCMKTS:APYI) vs. Hims & Hers Health (NYSE:HIMS)

Aspyra (OTCMKTS:APYI) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Aspyra and Hims & Hers Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aspyra	0	0	0	0	0.00
Hims & Hers Health	3	10	4	0	2.06

Hims & Hers Health has a consensus price target of $28.70, indicating a potential upside of 6.89%. Given Hims & Hers Health’s stronger consensus rating and higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than Aspyra.

Volatility & Risk

Aspyra has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the S&P 500.

Profitability

This table compares Aspyra and Hims & Hers Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aspyra	N/A	N/A	N/A
Hims & Hers Health	-0.56%	6.10%	1.52%

Institutional & Insider Ownership

63.5% of Hims & Hers Health shares are held by institutional investors. 23.9% of Aspyra shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Aspyra and Hims & Hers Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aspyra	N/A	N/A	N/A	N/A	N/A
Hims & Hers Health	$2.35 billion	2.65	$128.37 million	($0.09)	-298.33

Hims & Hers Health has higher revenue and earnings than Aspyra.

Summary

Hims & Hers Health beats Aspyra on 8 of the 10 factors compared between the two stocks.

About Aspyra

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.